Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

Recent & Breaking News (TSX:TST)

Purpose Investments Inc. Announces Reversal of Intent to Terminate Purpose Canadian Financial Income Fund

GlobeNewswire July 21, 2020

Purpose Investments Inc. Announces Termination of Purpose Canadian Financial Income Fund

GlobeNewswire June 24, 2020

Uncertainty Returns to Healthcare Industry Out-of-Court Restructurings with Senate Rejecting ACA Repeal

PR Newswire August 15, 2017

Telesta Therapeutics Inc. announces closing of arrangement with Prometic Life Sciences Inc.

Canada NewsWire October 31, 2016

Telesta Therapeutics Inc. announces final court approval of plan of arrangement with ProMetic Life Sciences Inc.

PR Newswire October 28, 2016

Telesta Therapeutics Inc. shareholders approve plan of arrangement with ProMetic Life Sciences Inc.

Canada NewsWire October 25, 2016

Leading Independent Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Plan of Arrangement between Telesta Therapeutics Inc. and ProMetic Life Sciences Inc.

Canada NewsWire October 11, 2016

Leading Independent Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Plan of Arrangement between Telesta Therapeutics Inc. and ProMetic Life Sciences Inc.

PR Newswire October 11, 2016

Telesta Therapeutics Publishes its Annual Financial Statements and Provides Date of Special Shareholders Meeting

Canada NewsWire September 19, 2016

Telesta Therapeutics Announces Execution of a Binding Purchase Agreement from ProMetic Life Sciences Inc.

Canada NewsWire August 24, 2016

Telesta Therapeutics Announces Execution of a Binding Purchase Agreement from ProMetic Life Sciences Inc.

PR Newswire August 24, 2016

Telesta Therapeutics Provides Strategic Update

Canada NewsWire August 2, 2016

Telesta Therapeutics Publishes its Q3, 2016 Financial Statements and Provides Corporate Updates

Canada NewsWire May 10, 2016

Telesta Announces Type A Meeting Results and Strategic Option Review

Canada NewsWire April 18, 2016

Telesta Therapeutics Corporate Update - Type A Meeting with the FDA Scheduled

Canada NewsWire April 12, 2016

Telesta Therapeutics Provides Corporate Update

Canada NewsWire March 9, 2016

Telesta Therapeutics Publishes its Q2, 2016 Financial Statements and Provides Corporate Updates

Canada NewsWire February 12, 2016

MicroCap Report: Telesta Therapeutics (T.TST) climbs, Dundee Precious Metals (T.DPM) falls

Stockhouse Editorial February 10, 2016

Telesta Therapeutics (T.TST) slammed down 76% after FDA delay

Chris Parry February 2, 2016

IIROC Trade Resumption - Telesta Therapeutics Inc.

Newsfile February 2, 2016